CA
PFE icon

COFG Advisors’s Pfizer PFE Stock Holding History

COFG Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458K Buy
19,000
+1,461
+8% +$38.2K 0.08% 179
2026
Q1 		$492K Buy
17,539
+753
+4% +$20K 0.12% 119
2025
Q4 		$418K Buy
+16,786
New +$423K 0.1% 137

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

COFG Advisors's PFE Position: Q2 2026 in Review

COFG Advisors increased its Pfizer (PFE) stake by 8.3% in Q2 2026, buying an estimated $38.2K and bringing the position to 19,000 shares worth $458K. The position accounts for 0.08% of the portfolio, ranked #179.

COFG Advisors first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $492K in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • COFG Advisors held 19,000 shares of Pfizer worth $458K as of Q2 2026.
  • COFG Advisors bought 1,461 Pfizer shares in Q2 2026, an estimated $38.2K.
  • Pfizer made up 0.08% of COFG Advisors's portfolio in Q2 2026, its #179 holding.
  • COFG Advisors first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • COFG Advisors's Pfizer position peaked at $492K in Q1 2026.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on COFG Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.